Advertisement

Topics

Symphogen A/S Company Profile

15:56 EST 16th December 2018 | BioPortfolio

Symphogen A/S, the biotech company pioneering recombinant human polyclonal antibodies for the treatment and prevention of human disease, today announced the initial closing of a USD 25 million Series D financing at a premium to the last financing round.

Location

Elektrovej Building 375
Lyngby,
DK-2800
Denmark

Contact

Phone: 45 4526 5050
Fax: 45 4526 5060
Email: info@symphogen.com


News Articles [11 Associated News Articles listed on BioPortfolio]

Selexis, Symphogen Expand Partnership

Under the terms of an earlier license agreement, Symphogen has opened two INDs for clinical programs utilizing Selexis’ SGE

Selexis and Symphogen expand partnership to progress two mAbs

Selexis and Symphogen have announced that the latter has submitted INDs for clinical programmes to progress two mAbs using Selexisâ platform.

Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins

Thermo Fisher and Symphogen to develop new workflows to characterize and monitor the quality of mixed antibody products. Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a...

Symphogen A/S and Selexis Expand Relationship as Symphogen Advances its Monoclonal Antibody (mAb) Mixture Pipeline

Selexis SA today announced that under the terms of an earlier commercial license agreement, Symphogen A/S has opened two investigational new drug applications (INDs) for ...

Thermo Fisher, Symphogen Enter Collaboration

To deliver validated, platform workflows for simplified characterization & quality monitoring of complex therapeutic proteins

Symphogen AS Strategic SWOT Analysis Review [Report Updated: 27062018] Prices from USD $125

Symphogen AS Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT ana...

Symphogen Selects TransPerfect’s Trial Interactive eTMF Technology and Services

TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today ann...

Thermo Fisher and Symphogen collaborate on complex therapeutic proteins

Laboratory equipment supplier Thermo Fisher Scientific has entered into a two-year collaborative partnership with Symphogen, a clinical-stage antibody oncology-focused company, to deliver validated, p...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Symphogen

Symphogen is developing superior antibody therapeutics (monoclonal, monoclonal mixtures and polyclonal) to help people with serious diseases and significant unmet medical needs. W...

Symphogen A/S

Symphogen A/S, the biotech company pioneering recombinant human polyclonal antibodies for the treatment and prevention of human disease, today announced the initial closing of a USD 25 million Series ...

More Information about "Symphogen A/S" on BioPortfolio

We have published hundreds of Symphogen A/S news stories on BioPortfolio along with dozens of Symphogen A/S Clinical Trials and PubMed Articles about Symphogen A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Symphogen A/S Companies in our database. You can also find out about relevant Symphogen A/S Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record